
DL-Glyceraldehyde NEW
Price | $47 | $76 | $112 |
Package | 10mg | 25mg | 50mg |
Min. Order: | |
Supply Ability: | 10g |
Update Time: | 2025-04-27 |
Product Details
Product Name: DL-Glyceraldehyde | CAS No.: 56-82-6 |
Purity: 90% | Supply Ability: 10g |
Release date: 2025/04/27 |
Product Introduction
Bioactivity
Name | DL-Glyceraldehyde |
Description | DL-Glyceraldehyde (Glyceric aldehyde) is produced from the action of the enzyme glyceraldehyde dehydrogenase, which converts glycerol to glyceraldehyde using NADP as a cofactor. When present at sufficiently high levels, DL-Glyceraldehyde can be a cytotoxin and a mutagen. A cytotoxin is a compound that kills cells. A mutagen is a compound that causes mutations in DNA. DL-Glyceraldehyde is a highly reactive compound that can modify and cross-link proteins. DL-Glyceraldehyde modified proteins appear to be cytotoxic, depress intracellular glutathione levels, and induce reactive oxygen species (ROS) production (PMID: 14981296 ). DL-Glyceraldehyde has been shown to cause chromosome damage to human cells in culture and is mutagenic in the Ames bacterial test. |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Solubility Information | DMSO : 4.4 mg/mL (48.85 mM), Sonication is recommended. |
Keywords | DL-Glyceraldehyde | DLGlyceraldehyde | DL Glyceraldehyde | Aldose reductase |
Inhibitors Related | MK 0434 | Alconil | Epalrestat | D-Methionine sulfoxide | 2-Chloro-1-(4-fluorobenzyl)benzimidazole | Tolrestat | Lidorestat | Alpha-Estradiol | Isoliquiritigenin | Finasteride | Epristeride | Dutasteride |
Related Compound Libraries | Glycometabolism Compound Library | Bioactive Compound Library | Saccharide and Glycoside Natural Product Library | Natural Product Library | Natural Product Library for HTS | RO5 Drug-like Natural Product Library | Human Endogenous Metabolite Library | Anti-infective Natural Product Library | Bioactive Compounds Library Max | Covalent Inhibitor Library | Gut Microbial Metabolite Library | Anti-Metabolism Disease Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
Product name | Price | Suppliers | Update time | |
---|---|---|---|---|
$190.00/500U |
VIP3Y
|
TargetMol Chemicals Inc.
|
2024-11-19 | |
$0.00/1kg |
VIP2Y
|
Sichuan HongRi Pharma-Tech Co.,Ltd
|
2024-04-10 | |
$80.00/1kg |
Hebei Zhuanglai Chemical Trading Co.,Ltd
|
2024-04-23 | ||
$1.00/1KG |
VIP7Y
|
Career Henan Chemical Co
|
2018-12-24 |
- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY